Enhabit, Inc. (NYSEEHAB), a leading home health and hospice provider, announced today that it is proud to be Certified™ by Great Place To Work®. This prestigious award is based entirely on the experiences of current employees working at Enhabit. This year, 83% of employees said it’s a great place to work, which is 26 points higher than the average U.S. company.

On Monday, Encompass Health and Enhabit won their lawsuit in the Delaware Court of Chancery related to breaches of fiduciary duty by April Anthony, Luke James, and Chris Walker while they served as the senior officers at Encompass Health’s former home health and hospice division, which is now Enhabit. The Court awarded judgment against private equity firms Vistria Group and Nautic Partners and the home health and hospice business now known as VitalCaring Group for aiding and abetting “the egregious breaches of the duty of loyalty” by Anthony, James, and Walker.

Enhabit, Inc. (NYSEEHAB), a leading home health and hospice provider, today announced its participation in the upcoming BofA Securities 2024 Home Care Conference.

Enhabit, Inc. (NYSEEHAB), (“Enhabit”), a leading home health and hospice provider, today announced the appointment of Ryan Solomon as its next chief financial officer (CFO), effective Dec. 9, 2024. Mr. Solomon’s appointment follows the previously announced transition of Crissy Carlisle, CFO.

Enhabit, Inc. (NYSEEHAB), a leading home health and hospice care provider, today reported its results of operations for the third quarter ended September 30, 2024.

Enhabit, Inc. (NYSEEHAB), a leading home health and hospice provider, today announced its recognition by the Institute for Healthcare Improvement (IHI) as an Age-Friendly Health Systems Participant.

Enhabit, Inc. (NYSEEHAB), a leading national home health and hospice provider, today announced it will report its results for the third quarter ended Sept. 30, 2024, on Nov. 6, 2024, and host a webcast and conference call on Nov. 7, 2024. Individuals who would like to participate in the conference call webcast should join 15 minutes before the scheduled start time.

Enhabit, Inc. (NYSEEHAB), a leading home health and hospice provider, today announced its participation in two upcoming investor conferences.

Enhabit, Inc. (NYSEEHAB), (“Enhabit” or the “Company”), a leading home health and hospice care provider, today announced that Crissy Carlisle, chief financial officer, will step down from her role as CFO.

Enhabit, Inc. (NYSEEHAB), a leading home health and hospice care provider, today reported its results of operations for the second quarter ended June 30, 2024.

AREX Capital Management, LP (together with its affiliates, “AREX”), the beneficial owner of approximately 4.9% of the outstanding common shares of Enhabit, Inc. (NYSEEHAB) (“Enhabit” or the “Company”), today commented on the outcome of Enhabit’s 2024 Annual Meeting of Stockholders (the “Annual Meeting”), in which stockholders elected Mark W. Ohlendorf to the Company’s board of directors (the “Board”).

Enhabit, Inc. (NYSEEHAB) (the “Company”), a leading home health and hospice provider, today announced that the preliminary vote count of its proxy solicitor indicates that its stockholders have voted to elect eight of Enhabit’s director nominees at the 2024 Annual Meeting of Stockholders:

AREX Capital Management, LP (together with its affiliates, “AREX”), the beneficial owner of approximately 4.9% of the outstanding common shares of Enhabit, Inc. (NYSEEHAB) (“Enhabit” or the “Company”), today issued an open letter to its fellow stockholders asking them to address the deficiencies of Enhabit’s current board of directors by electing the full AREX slate, which AREX believes will support the creation of long-term value for all stockholders.

Enhabit, Inc. (NYSEEHAB) (“Enhabit” or the “Company”), a leading home health and hospice provider, today reminded stockholders to protect the value of their investment by voting ahead of the 2024 Annual Meeting of Stockholders (the “2024 Annual Meeting”) which will be held on July 25, 2024. Stockholders of record as of the close of business on June 5, 2024, are entitled to vote at the Annual Meeting.

AREX Capital Management, LP (together with its affiliates, “AREX”), the beneficial owner of approximately 4.9% of the outstanding common shares of Enhabit, Inc. (NYSEEHAB) (“Enhabit” or the “Company”), today announced that Glass, Lewis & Co. (“Glass Lewis”), a leading independent proxy advisory firm, has recommended that Enhabit’s stockholders support significant boardroom change by voting for three of its director candidates at the Company’s 2024 Annual Meeting of Stockholders (the “Annual Meeting”) on July 25, 2024. Glass Lewis recommends that stockholders elect Maxine Hochhauser, Mark W. Ohlendorf, and Dr. Gregory S. Sheff to Enhabit’s board of directors (the “Board”). Previously, Institutional Shareholder Services Inc. recommended that stockholders elect three of AREX’s director candidates.

Enhabit, Inc. (NYSEEHAB) (“Enhabit” or the “Company”), a leading home health and hospice provider, today announced certain unaudited preliminary results for the second quarter ended June 30, 2024. The Company plans to report actual second quarter 2024 financial results on Aug. 6, 2024, and host a webcast and conference call on Aug. 7, 2024.

AREX Capital Management, LP (together with its affiliates, “AREX”), the beneficial owner of approximately 4.9% of the outstanding common shares of Enhabit, Inc. (NYSEEHAB) (“Enhabit” or the “Company”), today announced that Institutional Shareholder Services Inc. (“ISS”), a leading independent proxy advisory firm, has recommended that Enhabit’s stockholders support meaningful boardroom change by voting for three of its director candidates at the Company’s 2024 Annual Meeting of Stockholders (the “Annual Meeting”) on July 25, 2024. ISS recommends that stockholders elect Anna-Gene O’Neal, Mark W. Ohlendorf, and Dr. Gregory S. Sheff to Enhabit’s Board of Directors (the “Board”).

Enhabit, Inc. (NYSEEHAB) (“Enhabit” or the “Company”), a leading home health and hospice provider, today announced that Institutional Shareholder Services (ISS) has recommended stockholders vote “FOR” a majority of Enhabit’s director nominees in connection with the Company’s Annual Meeting of Stockholders scheduled for July 25, 2024.

Enhabit, Inc. (NYSEEHAB), a leading national home health and hospice provider, today announced it will report its results for the second quarter ended June 30, 2024, on Aug. 6, 2024, and host a webcast and conference call on Aug. 7, 2024. Individuals who would like to participate in the conference call webcast should join 15 minutes before the scheduled start time.

Enhabit, Inc. (NYSEEHAB) (“Enhabit” or the “Company”), a leading home health and hospice provider, today sent a letter to stockholders in connection with its upcoming 2024 Annual Meeting of Stockholders scheduled for July 25, 2024. Stockholders of record, as of the close of business on June 5, 2024, are entitled to vote at the 2024 Annual Meeting.

AREX Capital Management, LP (together with its affiliates, “AREX”), the beneficial owner of approximately 4.9% of the outstanding common shares of Enhabit, Inc. (NYSEEHAB) (“Enhabit” or the “Company”), today issued an open letter to its fellow stockholders expressing its disappointment in the Company’s recent investor presentation, which it believes recycles the same excuses and makes the same empty promises on which the Company has repeatedly failed to deliver.

Enhabit, Inc. (NYSEEHAB), a leading home health and hospice provider, today announced that it has posted an investor presentation today in connection with its Annual Meeting of Stockholders (the “2024 Annual Meeting”) scheduled for July 25, 2024. Stockholders of record as of the close of business on June 5, 2024, are entitled to vote at the 2024 Annual Meeting. The presentation can be found at investors.ehab.com/2024-annual-meeting/.

AREX Capital Management, LP (together with its affiliates, “AREX”), the beneficial owner of approximately 4.9% of the outstanding common shares of Enhabit, Inc. (NYSEEHAB) (“Enhabit” or the “Company”), today issued a presentation detailing the AREX Slate’s comprehensive plan to turn around Enhabit’s operational performance and reduce costs, which AREX believes could increase EBITDA by 50%.

Enhabit, Inc. (NYSEEHAB), (“Enhabit” or the “Company”), a leading home health and hospice provider, today sent a letter to stockholders in connection with its upcoming 2024 Annual Meeting of Stockholders (the “2024 Annual Meeting”) scheduled for July 25, 2024. Stockholders of record as of the close of business on June 5, 2024 are entitled to vote at the 2024 Annual Meeting.